Valuation: HealthBeacon plc

Market Cap 1.19M 1.03M 965K 886K 1.67M 113M 1.7M 11.38M 4.46M 56.53M 4.47M 4.37M 186M P/E 2021
-7.86x
P/E 2022 -2.89x
Enterprise Value -10.27M -8.92M -8.33M -7.65M -14.42M -979M -14.67M -98.24M -38.47M -488M -38.57M -37.71M -1.61B EV / Sales 2021
35.5x
EV / Sales 2022 12.1x
Free-Float
59.75%
Yield 2021 *
-
Yield 2022 -
3 years 0.06
Extreme 0.0645
1.9
5 years 0.06
Extreme 0.0645
6.24
10 years 0.06
Extreme 0.0645
6.24
Manager TitleAgeSince
Chief Executive Officer 73 2023-09-25
Chief Tech/Sci/R&D Officer - 2012-12-31
Director of Finance/CFO - 2022-12-20
Director TitleAgeSince
Chairman 55 2021-11-21
Director/Board Member 73 2020-09-07
Director/Board Member 73 2021-11-21
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-96.32% 1.29M
+1.34%+2.52%-15.85%-0.39% 185B
+1.51%+2.92%-2.98%+2.59% 111B
-0.95%-0.89%+6.94%+61.15% 60B
+2.63%+9.46%+43.51%+59.34% 53.9B
+2.77%+7.10%-3.49%-36.65% 46.9B
+3.03%+1.94% - - 34.22B
+4.63%+19.00%+10.13%-28.48% 32.95B
+2.05%+5.04%+45.42%-5.89% 24.49B
+1.86%+6.52%+2.54%+3.17% 22.67B
Average +1.49%+4.65%+9.58%-4.61% 57.14B
Weighted average by Cap. +0.53%+3.77%+1.55%+8.10%

Financials

2021 2022
Net sales 2.21M 1.92M 1.8M 1.65M 3.11M 211M 3.16M 21.18M 8.3M 105M 8.32M 8.13M 347M 2.25M 1.96M 1.83M 1.68M 3.16M 214M 3.22M 21.53M 8.43M 107M 8.45M 8.26M 353M
Net income -8.21M -7.13M -6.66M -6.11M -11.53M -782M -11.73M -78.54M -30.76M -390M -30.83M -30.15M -1.29B -13.24M -11.51M -10.75M -9.87M -18.6M -1.26B -18.93M -127M -49.63M -630M -49.75M -48.65M -2.08B
Net Debt -26.34M -22.89M -21.37M -19.62M -36.99M -2.51B -37.64M -252M -98.69M -1.25B -98.93M -96.74M -4.13B -11.46M -9.96M -9.3M -8.53M -16.09M -1.09B -16.37M -110M -42.93M -545M -43.03M -42.08M -1.8B
Logo HealthBeacon plc
Healthbeacon Ltd, formerly HealthBeacon plc, is an Ireland-based digital therapeutics company. The Company develops products for managing injectable medications for patients in the home. The Company operates through two segments: Direct-to-Consumer (DTC) and Patient Support Programmes (PSP). Its Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence-driven data analytics. It accesses the end patient through three distinct distribution channels, such as PSP, DTC, and Reimbursed Digital Therapeutics. It delivers technology-enabled waste management solutions. It also develops smart tools for managing medications. The Company operates in over 17 countries primarily across Europe, North America, and the United Kingdom.
Employees
70
  1. Stock Market
  2. Stocks
  3. HBCN Stock